Event Brief
Health Canada approves first generic Ozempic
Filed: Apr 28, 2026 at 7:04 PM ET
Summary: Health Canada approved the first generic version of Ozempic, a once-weekly injectable semaglutide for adults with Type 2 diabetes.
WHO: Health Canada
WHAT: Approval of the first generic version of Ozempic (semaglutide)
WHEN: Apr 28, 2026 at 6:44 PM ET
WHERE: Canada
WHY: No specific cause was reported.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →